InspireMD reported a quarterly loss of $0.14 per share versus the Zacks consensus loss of $0.22, beating estimates by $0.08 and improving from a $0.19 loss a year ago (a $0.05 year-over-year improvement). The result represents a modest earnings beat that is likely to have a small positive impact on the stock but is not material to broader markets.
InspireMD reported a quarterly loss of $0.14 per share versus the Zacks consensus loss of $0.22, beating estimates by $0.08 and improving from a $0.19 loss a year ago (a $0.05 year-over-year improvement). The result represents a modest earnings beat that is likely to have a small positive impact on the stock but is not material to broader markets.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request DemoOverall Sentiment
mildly positive
Sentiment Score
0.25
Ticker Sentiment
